Clinical trial / 2007
Oral intake of 40 mg/day of soy isoflavone aglycone improved fine wrinkles and malar skin elasticity in middle-aged women.
Twenty-six women in their late 30s and early 40s were randomly assigned to receive 40 mg/day of soy isoflavone aglycone (13 women) or placebo (13 women) for 12 weeks. Compared with placebo, the soy isoflavone aglycone group showed statistically significant improvement in fine wrinkles at week 12 (p<0.05) and malar skin elasticity at week 8 (p<0.05). Skin microrelief at the lateral angle of the eyes did not significantly differ between groups, though an intragroup improvement occurred at week 8 in the test group (p<0.05). No adverse symptoms were reported during the study.
- Study type
- Double-blind, placebo-controlled randomized trial
- Who was studied
- 26 female volunteers in their late 30s and early 40s
- What was measured
- Wrinkles' area ratio at the lateral angle of eyes, skin microrelief, and malar skin elasticity
THE PAPER
Oral intake of soy isoflavone aglycone improves the aged skin of adult women.
Izumi T, Saito M, Obata A, Arii M, Yamaguchi H, Matsuyama A. J Nutr Sci Vitaminol (Tokyo), 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.